Thank you, Eric and welcome to everyone. First of all, I would like to review the highlights of our Q2 results and in that regard, I am pleased to report that the second quarter developed as we anticipated. In reviewing our results in detail, you have seen that we again reported healthy revenues, operating margins, and net profit for the quarter. Second quarter revenues were recorded at EUR935 million, roughly averaging what we achieved in the past five quarters. As announced earlier, we have taken a deliberate decision to invest further in R&D and that’s why the operating cost increased in Q2 by EUR4 million to EUR177 million, while keeping our SG&A flat. Posting 41.1% gross margin that resulted in an operating margin in the quarter of 22.2% versus 20.5%, in Q1. We do remain highly flexible and adaptive to market cycles and although we continue to grow our operational cost base to support our future growth in both our R&D spending and SG&A costs. We keep focusing on creating cost scalability such that we can manage the profitability in any market condition. As a reminder, about 30% of R&D costs are variable within a quarter's time, and approximately 10% of SG&A costs are variable. Cash flows - cash flow for the second quarter remained well above our operating needs, with net cash from operations in the second quarter at EUR260 million versus EUR173 million in Q1. Also in Q2, we made an announcement on our plan to optimize our capital structure with the issuance of our benchmark Eurobond, followed by a capital repayment and a reverse stock split, which in essence is a synthetic share buyback. And this will result in an 11% reduction in outstanding shares count. We successfully completed the Eurobond issuance on June 13, raising a total of about EUR600 million to be used to fund, and a EUR960 million return of capital to shareholders. This was approved yesterday at the shareholders meeting. This resulted in a quarter-end cash balance of EUR2.3 billion and a EUR960 million return of capital, which we expect to be completed before the end of the third quarter, or by the end of the third quarter. A gross cash balance of EUR1.3 billion will remain. Following four strong order quarters, we experienced an expected drop in net bookings in Q2. Total system orders of 30 units, with a value of EUR400 million, left us with a backup value of EUR1.7 billion. And as we predicted, our memory customers hit the peak in terms of older capacity in Q2 and did need to order after several quarters of strong capacity ordering. Our foundry customers have seen clear improvements in their factory utilization, although an object at the level that they needed to place orders in Q2. All in all, Q2 was a quarter of order digestion, a clear pause in an otherwise, healthy secular trend. Order intakes for leading-edge technology was good especially focusing on our immersion product offering. But this has left in Q2, to a record order at a selling price of close to EUR17 million per system for new systems. And the total number of immersion systems in the backlog is 25, with a total value of EUR728 million. That is all being to the outlook, with regard to Q3, it is still difficult to call the exact timing of our bookings. At the exact speed of the order ramp, we will indeed be dependent on the semiconductor Christmas season poll and the resulting framing up of the memory pricing. However, we do believe that we have seen the bottom of the order cycle and our belief is based on several data points. First, our internal simulation of excess capacity in the memory segment for both DRAM and flash as indicated for sometime now, and supply the remaining balance by the end of the year. We do see additional external evidence of this: a fair pricing for DRAM and flash products; higher than expected DRAM unit growth; and recent increased customer inquiries into our ability to serve their additional capacity needs towards the end of the year. Secondly, the increasing utilization trend of our foundry customers' is most noticeable in the 200 millimeter segment, where we believe capacity is currently tight. This is reflected in an increased customer attention for used equipment that will translate into orders. For 300 millimeter capacity, we have seen utilization clearly trending upwards, making the need for additional capacity in the Q4 to Q1 timeframe, very plausible. And thirdly, we have strong confidence in the execution of our leading-edge technology roadmap. Our 1900i has shown solid performance, clearly meeting our expectations. 2008 technology transition for NAND customer to sub-50-nanometer features, and DRAM and foundry customers to sub-60-nanometer features, will be a strong driver for leading-edge technology orders. So in summary, we believe that we have seen the order thrive in Q2, and we are looking at an increased order momentum, accelerating in the second half of this year. With this, I would like to end my part of the introduction. And I would like to turn back to you, Eric.